-
1
-
-
42349085052
-
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia
-
DOI 10.1038/leu.2008.5, PII LEU20085
-
Flohr T, Schrauder A, Cazzaniga G, et al International BFM Study Group (I-BFM-SG). Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia. 2008;22(4):771-782. (Pubitemid 351552626)
-
(2008)
Leukemia
, vol.22
, Issue.4
, pp. 771-782
-
-
Flohr, T.1
Schrauder, A.2
Cazzaniga, G.3
Panzer-Grumayer, R.4
Van Der Velden, V.5
Fischer, S.6
Stanulla, M.7
Basso, G.8
Niggli, F.K.9
Schafer, B.W.10
Sutton, R.11
Koehler, R.12
Zimmermann, M.13
Valsecchi, M.G.14
Gadner, H.15
Masera, G.16
Schrappe, M.17
Van Dongen, J.J.M.18
Biondi, A.19
Bartram, C.R.20
more..
-
2
-
-
77951441599
-
Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: Results in 3184 patients of the AIEOPBFM ALL 2000 study
-
Conter V, Bartram CR, Valsecchi MG, et al. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOPBFM ALL 2000 study. Blood. 2010;115(16):3206-3214.
-
(2010)
Blood
, vol.115
, Issue.16
, pp. 3206-3214
-
-
Conter, V.1
Bartram, C.R.2
Valsecchi, M.G.3
-
3
-
-
0032576355
-
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
-
Schrappe M, Valsecchi MG, Bartram CR, et al. Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study. Blood. 2011;118(8):2077-2084. 4. van Dongen JJ, Seriu T, Panzer-Grümayer ER, et al. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet. 1998;352(9142):1731-1738. (Pubitemid 28534955)
-
(1998)
Lancet
, vol.352
, Issue.9142
, pp. 1731-1738
-
-
Van Dongen, J.J.M.1
Seriu, T.2
Panzer-Grumayer, E.R.3
Biondi, A.4
Pongers-Willemse, M.J.5
Corral, L.6
Stolz, F.7
Schrappe, M.8
Masera, G.9
Kamps, W.A.10
Gadner, H.11
Van Wering, E.R.12
Ludwig, W.-D.13
Basso, G.14
De Bruijn, M.A.C.15
Cazzaniga, G.16
Hettinger, K.17
Van Der D.-Van, D.B.A.18
Hop, W.C.J.19
Riehm, H.20
Bartram, C.R.21
more..
-
4
-
-
0031790803
-
Intensive BFM chemotherapy for childhood ALL: Interim analysis of the AIEOP-ALL 91 study
-
Conter V, Aricò M, Valsecchi MG, et al. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica. Haematologica. 1998;83(9):791-799. (Pubitemid 28496168)
-
(1998)
Haematologica
, vol.83
, Issue.9
, pp. 791-799
-
-
Conter, V.1
Arico, M.2
Valsecchi, M.G.3
Rizzari, C.4
Testi, A.5
Miniero, R.6
Di, T.M.T.7
Lo, N.L.8
Pession, A.9
Rondelli, R.10
Messina, C.11
Santoro, N.12
Mori, P.G.13
De Rossi, G.14
Tamaro, P.15
Silvestri, D.16
Biondi, A.17
Basso, G.18
Masera, G.19
-
5
-
-
0034210549
-
Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: Results of trial ALL- BFM 90
-
Schrappe M, Reiter A, Ludwig WD, et al German-Austrian-Swiss ALL-BFM Study Group. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. Blood. 2000;95(11):3310-3322. (Pubitemid 30428458)
-
(2000)
Blood
, vol.95
, Issue.11
, pp. 3310-3322
-
-
Schrappe, M.1
Reiter, A.2
Ludwig, W.-D.3
Harbott, J.4
Zimmermann, M.5
Hiddemann, W.6
Niemeyer, C.7
Henze, G.8
Feldges, A.9
Zintl, F.10
Kornhuber, B.11
Ritter, J.12
Welte, K.13
Gadner, H.14
Riehm, H.15
-
6
-
-
0037100416
-
Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt- Muenster protocol ii
-
DOI 10.1182/blood.V100.2.420
-
Aricò M, Valsecchi MG, Conter V, et al. Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisonepoor response treated with double Berlin- Frankfurt-Muenster protocol II. Blood. 2002;100(2):420-426. (Pubitemid 34761102)
-
(2002)
Blood
, vol.100
, Issue.2
, pp. 420-426
-
-
Arico, M.1
Valsecchi, M.G.2
Conter, V.3
Rizzari, C.4
Pession, A.5
Messina, C.6
Barisone, E.7
Poggi, V.8
De Rossi, G.9
Locatelli, F.10
Micalizzi, M.C.11
Basso, G.12
Masera, G.13
-
7
-
-
38349143355
-
Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: Insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy
-
Aricò M, Valsecchi MG, Rizzari C, et al. Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy. J Clin Oncol. 2008;26(2):283-289.
-
(2008)
J Clin Oncol
, vol.26
, Issue.2
, pp. 283-289
-
-
Aricò, M.1
Valsecchi, M.G.2
Rizzari, C.3
-
8
-
-
47149100125
-
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: Treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95
-
German-Austrian-Swiss ALL-BFM Study Group
-
Möricke A, Reiter A, Zimmermann M, et al German-Austrian-Swiss ALL-BFM Study Group. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood. 2008;111(9):4477-4489.
-
(2008)
Blood
, vol.111
, Issue.9
, pp. 4477-4489
-
-
Möricke, A.1
Reiter, A.2
Zimmermann, M.3
-
9
-
-
0034667685
-
Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia
-
Coustan-Smith E, Sancho J, Hancock ML, et al. Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood. 2000;96(8):2691-2696.
-
(2000)
Blood
, vol.96
, Issue.8
, pp. 2691-2696
-
-
Coustan-Smith, E.1
Sancho, J.2
Hancock, M.L.3
-
10
-
-
0032572924
-
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia
-
European Organization for Research and Treatment of Cancer-Childhood Leukemia Cooperative Group. European Organization for Research and Treatment of Cancer - Childhood Leukemia Cooperative Group
-
Cavé H, van der Werff ten Bosch J, Suciu S, et al; European Organization for Research and Treatment of Cancer-Childhood Leukemia Cooperative Group. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer - Childhood Leukemia Cooperative Group. N Engl J Med. 1998;339(9):591-598.
-
(1998)
N Engl J Med
, vol.339
, Issue.9
, pp. 591-598
-
-
Cavé, H.1
Van Der Werff Ten Bosch, J.2
Suciu, S.3
-
11
-
-
35148838428
-
Analyzing survival curves at a fixed point in time
-
DOI 10.1002/sim.2864
-
Klein JP, Logan B, Harhoff M, Andersen PK. Analyzing survival curves at a fixed point in time. Stat Med. 2007;26(24):4505-4519. (Pubitemid 47534694)
-
(2007)
Statistics in Medicine
, vol.26
, Issue.24
, pp. 4505-4519
-
-
Klein, J.P.1
Logan, B.2
Harhoff, M.3
Andersen, P.K.4
-
14
-
-
76749171200
-
Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia
-
Associazione Italiana di Ematologia ed Oncologia Pediatrica
-
Conter V, Aricò M, Basso G, et al; Associazione Italiana di Ematologia ed Oncologia Pediatrica. Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia. Leukemia. 2010;24(2):255-264.
-
(2010)
Leukemia
, vol.24
, Issue.2
, pp. 255-264
-
-
Conter, V.1
Aricò, M.2
Basso, G.3
-
15
-
-
76749102418
-
Longterm results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000
-
Möricke A, Zimmermann M, Reiter A, et al. Longterm results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia. 2010;24(2):265-284.
-
(2010)
Leukemia
, vol.24
, Issue.2
, pp. 265-284
-
-
Möricke, A.1
Zimmermann, M.2
Reiter, A.3
-
16
-
-
84866652995
-
Cognitive outcomes following contemporary treatment without cranial irradiation for childhood acute lymphoblastic leukemia
-
Conklin HM, Krull KR, Reddick WE, Pei D, Cheng C, Pui CH. Cognitive outcomes following contemporary treatment without cranial irradiation for childhood acute lymphoblastic leukemia. J Natl Cancer Inst. 2012;104(18):1386- 1395.
-
(2012)
J Natl Cancer Inst
, vol.104
, Issue.18
, pp. 1386-1395
-
-
Conklin, H.M.1
Krull, K.R.2
Reddick, W.E.3
Pei, D.4
Cheng, C.5
Pui, C.H.6
-
17
-
-
3042850886
-
The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia
-
DOI 10.1056/NEJMoa035153
-
Lipshultz SE, Rifai N, Dalton VM, et al. The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia. N Engl J Med. 2004;351(2):145-153. (Pubitemid 38886649)
-
(2004)
New England Journal of Medicine
, vol.351
, Issue.2
, pp. 145-153
-
-
Lipshultz, S.E.1
Rifai, N.2
Dalton, V.M.3
Levy, D.E.4
Silverman, L.B.5
Lipsitz, S.R.6
Colan, S.D.7
Asselin, B.L.8
Barr, R.D.9
Clavell, L.A.10
Hurwitz, C.A.11
Moghrabi, A.12
Samson, Y.13
Schorin, M.A.14
Gelber, R.D.15
Sallan, S.E.16
-
18
-
-
0038038460
-
Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia
-
Aricò M, Boccalatte MF, Silvestri D, et al; Associazione Italiana di Ematologia ed Oncologia Pediatrica. Osteonecrosis: an emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia. Haematologica. 2003;88(7):747-753. (Pubitemid 36890108)
-
(2003)
Haematologica
, vol.88
, Issue.7
, pp. 747-753
-
-
Arico, M.1
Pinta, B.M.F.2
Silvestri, D.3
Barisone, E.4
Messina, C.5
Chiesa, R.6
Santoro, N.7
Tamaro, P.8
Lippi, A.9
Gallisai, D.10
Basso, G.11
De Rossi, G.12
-
19
-
-
84865541969
-
Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: Results from the CCG-1961 randomised cohort trial
-
Children's Oncology Group
-
Mattano LA Jr, Devidas M, Nachman JB, et al Children's Oncology Group. Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial. Lancet Oncol. 2012;13(9):906-915.
-
(2012)
Lancet Oncol
, vol.13
, Issue.9
, pp. 906-915
-
-
Mattano Jr., L.A.1
Devidas, M.2
Nachman, J.B.3
-
20
-
-
84859534539
-
Outcomes after induction failure in childhood acute lymphoblastic leukemia
-
Schrappe M, Hunger SP, Pui CH, et al. Outcomes after induction failure in childhood acute lymphoblastic leukemia. N Engl J Med. 2012;366(15):1371-1381.
-
(2012)
N Engl J Med
, vol.366
, Issue.15
, pp. 1371-1381
-
-
Schrappe, M.1
Hunger, S.P.2
Pui, C.H.3
-
21
-
-
84865168175
-
Pediatric acute lymphoblastic leukemia: Where are we going and how do we get there?
-
Pui CH, Mullighan CG, Evans WE, Relling MV. Pediatric acute lymphoblastic leukemia: where are we going and how do we get there? Blood. 2012;120(6):1165-1174.
-
(2012)
Blood
, vol.120
, Issue.6
, pp. 1165-1174
-
-
Pui, C.H.1
Mullighan, C.G.2
Evans, W.E.3
Relling, M.V.4
-
22
-
-
44949166375
-
Eligibility for allogeneic transplantation in very high risk childhood acute lymphoblastic leukemia: The impact of the waiting time
-
DOI 10.3324/haematol.12291
-
Balduzzi A, De Lorenzo P, Schrauder A, et al. Eligibility for allogeneic transplantation in very high risk childhood acute lymphoblastic leukemia: the impact of the waiting time. Haematologica. 2008;93(6):925-929. (Pubitemid 351821732)
-
(2008)
Haematologica
, vol.93
, Issue.6
, pp. 925-929
-
-
Balduzzi, A.1
De Lorenzo, P.2
Schrauder, A.3
Conter, V.4
Uderzo, C.5
Peters, C.6
Klingebiel, T.7
Stary, J.8
Felice, M.S.9
Magyarosy, E.10
Schrappe, M.11
Dini, G.12
Gadner, H.13
Valsecchi, M.G.14
-
23
-
-
23844556272
-
Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: Comparison by genetic randomisation in an international prospective study
-
DOI 10.1016/S0140-6736(05)66998-X, PII S014067360566998X
-
Balduzzi A, Valsecchi MG, Uderzo C, et al. Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study. Lancet. 2005;366(9486):635-642. (Pubitemid 41176015)
-
(2005)
Lancet
, vol.366
, Issue.9486
, pp. 635-642
-
-
Balduzzi, A.1
Valsecchi, M.G.2
Uderzo, C.3
De Lorenzo, P.4
Klingebiel, T.5
Peters, C.6
Stary, J.7
Felice, M.S.8
Magyarosy, E.9
Conter, V.10
Reiter, A.11
Messina, C.12
Gadner, H.13
Schrappe, M.14
-
24
-
-
34247399924
-
Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: Results from ALL-BFM 90 and 95
-
DOI 10.1200/JCO.2006.06.2679
-
Schrauder A, Reiter A, Gadner H, et al. Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95. J Clin Oncol. 2006;24(36):5742-5749. (Pubitemid 46631317)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.36
, pp. 5742-5749
-
-
Schrauder, A.1
Reiter, A.2
Gadner, H.3
Niethammer, D.4
Klingebiel, T.5
Kremens, B.6
Peters, C.7
Ebell, W.8
Zimmermann, M.9
Niggli, F.10
Ludwig, W.-D.11
Riehm, H.12
Welte, K.13
Schrappe, M.14
-
25
-
-
84880308800
-
High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation
-
Marshall GM, Dalla Pozza L, Sutton R, et al. High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation. Leukemia. 2013;27(7):1497-1503.
-
(2013)
Leukemia
, vol.27
, Issue.7
, pp. 1497-1503
-
-
Marshall, G.M.1
Dalla Pozza, L.2
Sutton, R.3
|